The impact of luteinizing hormone in assisted reproduction: A review

Current Opinion in Obstetrics and Gynecology

Volumn 19, Issue 3, 2007, Pages 253-257

  Weghofer, Andrea ^a,b,c   Schnepf, Sarah ^d   Barad, David ^b,c,e   Gleicher, Norbert ^b,c,f  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b Center for Human Reproduction (CHR)   (United States)

^c Foundation for Reproductive Medicine   (United States)

^d KEPLER UNIVERSITY HOSPITAL   (Austria)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Follicle stimulating hormone; Gonadotrophin releasing hormone; In vitro fertilization; Luteinizing hormone; Ovarian reserve; Poor responder

Indexed keywords

GONADORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NIDATION; OOCYTE DONATION; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVARY; PREGNANCY; REPRODUCTION;

EID: 34248341794     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3280bad843     Document Type: Review

References (46)

1. Fevold H, Hisaw F, Leonard S. The gonad stimulating and the luteinizing hormones of the anterior lobe of the hypophesis. Am J Physiol 1931; 97:291-301.
2. Stein I, Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29:181-191.
3. Falck B. Site of production of oestrogen in rat ovary as studied in microtransplants. Acta Physiol Scand Suppl 1959; 47:1-101.
4. Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991; 6:1206-1212.
5. Shoham Z, Jacobs HS, Insler V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993; 59:1153-1161.
6. Kobayashi M, Nakano R, Ooshima A. Immunohistochemical localization of pituitary gonadotrophins and gonadal steroids confirms the 'two-cell, two-gonadotrophin' hypothesis of steroidogenesis in the human ovary. J Endocrinol 1990; 126:483-488.
7. Yamoto M, Shima K, Nakano R. Gonadotropin receptors in human ovarian follicles and corpora lutea throughout the menstrual cycle. Horm Res 1992; 37 (Suppl 1):5-11.
8. Barroso G, Oehninger S, Monzo A, et al. High FSH : LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet 2001; 18:499-505.
9. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000; 15:1003-1008.
10. Richards JS, Jahnsen T, Hedin L, et al. Ovarian follicular development: from physiology to molecular biology. Recent Prog Horm Res 1987; 43:231-276.
11. Karnitis VJ, Townson DH, Friedman CI, et al. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. J Clin Endocrinol Metab 1994; 79:91-97.
12. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 6th ed. Philadelphia: Lippincott, Williams and Wilkins; 1999.
13. Van Rooij IA, Bancsi LF, Broekmans FJ, et al. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 2003; 79:482-488.
14. Bjercke S, Fedorcsak P, Abyholm T, et al. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Hum Reprod 2005; 20:2441-2447.
15. Jurema MW, Bracero NJ, Garcia JE. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril 2003; 80:1156-1161.
16. Develioglu OH, Cox B, Toner JP, et al. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone. Hum Reprod 1999; 14:1168-1174.
17. Loumaye E, Engrand P, Howles CM, O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997; 67:889-899.
18. Penarrubia J, Fabregues F, Creus M, et al. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 2003; 18:2689-2697.
19. Lahoud R, Al-Jefout M, Tyler J, et al. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Hum Reprod 2006; 21:2645-2649. Comprehensive and informative work that introduces a new concept on the evaluation of luteinizing hormone differences in the prediction of ovarian function.
20. Fleming R, Lloyd F, Herbert M, et al. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998; 13:1788-1792.
21. Noci I, Biagiotti R, Maggi M, et al. Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod 1998; 13:531-534.
22. Liu SY, Han JL, Peng XD, et al. Effect of midfollicular luteinizing hormone levels on ovarian response and pregnancy outcome in patients undergoing in vitro fertilization in a short-term protocol. Fertil Steril 2005; 83:1043-1046.
23. Ho JY, Guu HF, Yi YC, et al. The serum follicle-stimulating hormone-toluteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict 'low responders'. Fertil Steril 2005; 83:883-888.
24. Shrim A, Elizur SE, Seidman DS, et al. Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response. Reprod Biomed Online 2006; 12:418-422. An accurate presentation of the predictive capacity of FSH : luteinizing hormone ratios in women who are at increased risk of profound luteinizing hormone suppression.
25. Mukherjee T, Copperman AB, Lapinski R, et al. An elevated day three follicle-stimulating hormone : luteinizing hormone ratio (FSH : LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996; 65:588-593.
26. Yamashita T, Ishimaru T, Fujishita A, et al. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme. Hum Reprod 1996; 11:1615-1619.
27. Weghofer A, Feichtinger W. The forgotten variable: impact of luteinizing hormone on the prediction of ovarian reserve. Fertil Steril 2006; 85:259-261.
28. Griesinger G, Diedrich K. Role of LH in ovarian stimulation: considerations. Reprod Biomed Online 2006; 12:404-406. A good review on the topic of luteinizing hormone.
29. Kol S. To add or not to add LH. Consideration of LH concentration changes in individual patients. Reprod Biomed Online 2005; 11:664-666.
30. Gleicher N, Vietzke M, Vidali A. Bye-bye urinary gonadotrophins? Recombinant FSH: a real progress in ovulation induction and IVF? Hum Reprod 2003; 18:476-482.
31. Griesinger G, Schultze-Mosgau A, Dafopoulos K, et al. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod 2005; 20:1200-1206.
32. Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2004; 19:1979-1984.
33. Chung K, Krey L, Katz J, Noyes N. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists. Fertil Steril 2005; 84:313-318.
34. Balasch J, Creus M, Fabregues F, et al. The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. J Assist Reprod Genet 2001; 18:250-256.
35. Balasch J, Penarrubia J, Fabregues F, et al. Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reprod Biomed Online 2003; 7:35-42.
36. De Placido G, Alviggi C, Perino A, et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005; 20:390-396.
37. De Placido G, Mollo A, Alviggi C, et al. Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum Reprod 2001; 16:1875-1879.
38. Drakakis P, Loutradis D, Kallianidis K, et al. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol 2005; 121:77-80.
39. Humaidan P, Bungum M, Bungum L, et al. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 2004; 8:635-643.
40. Lisi F, Rinaldi L, Fishel S, et al. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril 2005; 83:309-315.
41. Lisi F, Rinaldi L, Fishel S, et al. Use of recombinant LH in a group of unselected IVF patients. Reprod Biomed Online 2002; 5:104-108.
42. Commenges-Ducos M, Piault S, Papaxanthos A, et al. Recombinant folliclestimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2002; 78:1049-1054.
43. Ruvolo G, Bosco L, Pane A, et al. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril, 22 November 2006; e-pub ahead of print. An innovative approach to evaluate apoptosis rates after the application of luteinizing hormone.
44. Acevedo B, Sanchez M, Gomez JL, et al. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril 2004; 82:343-347.
45. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002; 17:3129-3137.
46. Weghofer A, Munne S, Brannath W, et al. The quantitative and qualitative impact of gonadotropin stimulation on human preimplantation embryos: a preliminary study. Fertil Steril 2006; 86:S58.